\(
\def\WIPO{World Intellectual Property Organisation}
\)
Details
Title
Treating a Substance as an Active Ingredient.
Item Type
Journal article
Description
1 online resource (pages 1074–1075)
Summary
Regulation No. 469/2009 concerning the supplementary protection certificate for medicinal products, Art. 1(b) – Trastuzumab Headnotes by the Editorial Office 1. The assessment of the specific pharmacological, immunological or metabolic action which is covered by the therapeutic indications of a substance must be made with a view to the contents of the marketing authorisation. 2. When the marketing authorisation does not categorise a substance as an ‘active ingredient’, there is a rebuttable presumption that this substance has no pharmacological, immunological or metabolic action of its own covered by the therapeutic indications of this marketing authorisation. Court of Cassation (Cour de cassation), judgment of 1 February 2023 – 101 FP-B on appeal D 21-15.221
Source of Description
Crossref
Series
GRUR International, 2632-8550 ; 72, 11, 2023.
Linked Resources
online version
Published
[Oxford, England] : Oxford University Press (OUP), 2023
Language
English
Copyright Information
https://academic.oup.com/grurint/article/72/3/231/6998505
Record Appears in
External Online Journals > GRUR